Cancer Research Communications Issues Research Articles in January 2024 Edition
February 12, 2024
February 12, 2024
PHILADELPHIA, Pennsylvania, Feb. 12 -- Cancer Research Communications, a peer-reviewed journal from the American Association for Cancer Research that says it stimulates innovation in cancer science and medicine, published research articles on the following topics in its January 2024 edition (Vol. 4, Issue 1):
* Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models
* Combined Inhibition of EZH2 and FGFR is Syn . . .
* Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models
* Combined Inhibition of EZH2 and FGFR is Syn . . .